. 2016 Jun 30;37(1):45–53. doi: 10.1111/liv.13186

Table 2.

Prevalence of hepatitis C virus (HCV) antibody and HCV RNA positive persons (age 15–59 years) by age, gender and region (EDHS 2008 and EHIS 2015 surveys)

Characteristic	HCV antibody positive				HCV RNA positive
Characteristic	% Positive 2008	% Positive 2015	Prevalence difference (95% CI)	% Prevalence reduction (95% CI)	% Positive 2008	% Positive 2015	Prevalence difference (95% CI)	% Prevalence reduction (95% CI)
Overall prevalence	14.7	10.0	4.7 (3.9–5.5)^a	32 (60–69)^a	9.9	7.0	2.9 (2.2–3.6)^a	29 (23–35)^a
Age group
15–19	4.1	1.0	3.1 (2.2–4.1)^a	75 (64–85)^a	2.8	0.8	2.2 (1.2–2.8)^a	73 (55–83)^a
20–24	4.9	3.2	1.6 (0.4–2.9)^a	34 (10–52)^a	3.0	2.2	0.8 (−0.2 to 1.8)	27 (−8.8 to 51)
25–29	6.1	4.4	1.7 (0.3–3.2)^a	28 (6–45)^a	3.9	3.0	0.9 (−0.2 to 2.1)	24 (−7 to 45)
30–34	11.8	7.1	4.5 (2.5–6.7)^a	40 (25–51)^a	8.3	4.9	3.3 (1.6–5.2)^a	41 (23–55)^a
35–39	13.8	8.2	5.5 (3.2–7.9)^a	40 (26–52)^a	9.9	6.0	3.8 (1.9–6.0)^a	39 (22–53)^a
40–44	23.0	11.6	11.4 (8.4–14.5)^a	50 (40–58)^a	15.0	8.9	6.1 (3.5–8.7)^a	41 (26–52)^a
45–49	28.6	16.3	12 (8.6–15.5)^a	43 (33–51)^a	18.9	11.5	7.3 (4.3–10.4)^a	39 (26–50)^a
50–54	38.3	27.9	10.6 (6.3–14.8)^a	27 (17–36)^a	25.3	19.7	5.6 (1.8–9.4)^a	22 (8–34)^a
55–59	39.4	33.9	5.1 (0.4–9.8)^a	14 (2–24)^a	27.4	22.3	5.0 (0.8–9.2)^a	18 (3–31)^a
Gender
Males	17.4	12.4	5 (3.7–6.2)^a	29 (22–35)^a	12.1	8.9	3.1 (2.1–4.3)^a	26 (18–34)^a
Females	12.2	8.1	4 (2.9–5.0)^a	33 (26–39)^a	7.8	5.5	2.3 (1.4–3.2)^a	30 (20–38)^a
Work status
Working for cash	18.8	13.3	5.5 (4.1–6.8)^a	29 (23–35)^a	13.0	9.5	3.5 (2.3–4.6)^a	27 (19–34)^a
Not working for cash	11.3	7.4	3.9 (2.9–4.8)^a	35 (28–41)^a	7.3	5.1	2.2 (1.4–3.0)^a	30 (21–38)^a
Region
Urban governorates	9.5	6.9	2.6 (0.98–4.21)^a	27 (11–41)^a	6.2	4.4	1.8 (0.4–3.0)^a	29 (8–45)^a
Lower Egypt	17.5	12.2	5.3 (4.0–6.6)^a	30 (24–36)^a	11.5	8.7	2.8 (1.7–3.9)^a	24 (16–32)^a
Upper Egypt	14.7	8.2	6.5 (6.9–9.5)^a	44 (37–50)^a	10.2	5.8	4.4 (3.2–5.5)^a	43 (35–50)^a
Frontier governorates	3.0	3.5	−0.2 (−5.7 to 5.0)	−17 (−369 to 71)	2.5	2.6	−0.1 (−5.2 to 4.6)	−4 (−402 to 78)

Statistically significant (P < 0.05).